Avanza Fonder’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.32M Buy
37,667
+7,612
+25% +$2.11M 0.18% 105
2026
Q1
$8.88M Sell
30,055
-2,715
-8% -$806K 0.25% 81
2025
Q4
$8.95M Buy
32,770
+3,526
+12% +$958K 0.23% 84
2025
Q3
$7.9M Buy
29,244
+2,688
+10% +$731K 0.2% 89
2025
Q2
$7.32M Buy
26,556
+4,052
+18% +$1.1M 0.22% 85
2025
Q1
$5.91M Sell
22,504
-4,014
-15% -$990K 0.19% 99
2024
Q4
$6.16M Buy
+26,518
New +$6.1M 0.18% 96

Other funds holding CME

Avanza Fonder's CME Position: Q2 2026 in Review

Avanza Fonder increased its CME Group (CME) stake by 25% in Q2 2026, buying an estimated $2.11M and bringing the position to 37,667 shares worth $8.32M. The position accounts for 0.18% of the portfolio, ranked #105.

Avanza Fonder first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.95M in Q4 2025. 599 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Avanza Fonder held 37,667 shares of CME Group worth $8.32M as of Q2 2026.
  • Avanza Fonder bought 7,612 CME Group shares in Q2 2026, an estimated $2.11M.
  • CME Group made up 0.18% of Avanza Fonder's portfolio in Q2 2026, its #105 holding.
  • Avanza Fonder first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's CME Group position peaked at $8.95M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.